Correlation Between DiaMedica Therapeutics and Tourmaline Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Tourmaline Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Tourmaline Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Tourmaline Bio, you can compare the effects of market volatilities on DiaMedica Therapeutics and Tourmaline Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Tourmaline Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Tourmaline Bio.

Diversification Opportunities for DiaMedica Therapeutics and Tourmaline Bio

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between DiaMedica and Tourmaline is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Tourmaline Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tourmaline Bio and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Tourmaline Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tourmaline Bio has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Tourmaline Bio go up and down completely randomly.

Pair Corralation between DiaMedica Therapeutics and Tourmaline Bio

Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 1.09 times more return on investment than Tourmaline Bio. However, DiaMedica Therapeutics is 1.09 times more volatile than Tourmaline Bio. It trades about 0.29 of its potential returns per unit of risk. Tourmaline Bio is currently generating about -0.14 per unit of risk. If you would invest  431.00  in DiaMedica Therapeutics on September 13, 2024 and sell it today you would earn a total of  135.00  from holding DiaMedica Therapeutics or generate 31.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

DiaMedica Therapeutics  vs.  Tourmaline Bio

 Performance 
       Timeline  
DiaMedica Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in DiaMedica Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, DiaMedica Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Tourmaline Bio 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Tourmaline Bio are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady primary indicators, Tourmaline Bio disclosed solid returns over the last few months and may actually be approaching a breakup point.

DiaMedica Therapeutics and Tourmaline Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DiaMedica Therapeutics and Tourmaline Bio

The main advantage of trading using opposite DiaMedica Therapeutics and Tourmaline Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Tourmaline Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tourmaline Bio will offset losses from the drop in Tourmaline Bio's long position.
The idea behind DiaMedica Therapeutics and Tourmaline Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.